91 related articles for article (PubMed ID: 26515793)
1. Impact of registration on clinical trials on infection risk in pediatric acute myeloid leukemia.
Dix D; Aplenc R; Bowes L; Cellot S; Ethier MC; Feusner J; Gillmeister B; Johnston DL; Lewis V; Michon B; Mitchell D; Portwine C; Price V; Silva M; Stobart K; Yanofsky R; Zelcer S; Beyene J; Sung L
Int J Cancer; 2016 Apr; 138(7):1785-91. PubMed ID: 26515793
[TBL] [Abstract][Full Text] [Related]
2. Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian infections in AML research group.
Dix D; Cellot S; Price V; Gillmeister B; Ethier MC; Johnston DL; Lewis V; Michon B; Mitchell D; Stobart K; Yanofsky R; Portwine C; Silva M; Bowes L; Zelcer S; Brossard J; Traubici J; Allen U; Beyene J; Sung L
Clin Infect Dis; 2012 Dec; 55(12):1608-14. PubMed ID: 22955431
[TBL] [Abstract][Full Text] [Related]
3. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.
Price V; Portwine C; Zelcer S; Ethier MC; Gillmeister B; Silva M; Schindera C; Yanofsky R; Mitchell D; Johnston DL; Lewis V; Dix D; Cellot S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2013 Jun; 32(6):610-3. PubMed ID: 23838731
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism in IL1B is associated with infection risk in paediatric acute myeloid leukaemia.
Sung L; Dix D; Cellot S; Gillmeister B; Ethier MC; Roslin NM; Johnston DL; Feusner J; Mitchell D; Lewis V; Aplenc R; Yanofsky R; Portwine C; Price V; Zelcer S; Silva M; Bowes L; Michon B; Stobart K; Traubici J; Allen U; Beyene J; den Hollander N; Paterson AD
Clin Microbiol Infect; 2016 Jun; 22(6):563.e9-563.e17. PubMed ID: 26932518
[TBL] [Abstract][Full Text] [Related]
6. Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004.
Bochennek K; Hassler A; Perner C; Gilfert J; Schöning S; Klingebiel T; Reinhardt D; Creutzig U; Lehrnbecher T
Blood Cancer J; 2016 Jan; 6(1):e382. PubMed ID: 26771808
[TBL] [Abstract][Full Text] [Related]
7. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
8. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
Lehrnbecher T; Varwig D; Kaiser J; Reinhardt D; Klingebiel T; Creutzig U
Leukemia; 2004 Jan; 18(1):72-7. PubMed ID: 14586478
[TBL] [Abstract][Full Text] [Related]
9. Infections in pediatric acute promyelocytic leukemia: from the Canadian infections in acute myeloid leukemia research group.
Cellot S; Johnston D; Dix D; Ethier MC; Gillmeister B; Mitchell D; Yanofsky R; Lewis V; Portwine C; Price V; Zelcer S; Silva M; Bowes L; Michon B; Stobart K; Brossard J; Beyene J; Sung L
BMC Cancer; 2013 Jun; 13():276. PubMed ID: 23735034
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
[TBL] [Abstract][Full Text] [Related]
11. Invasive Rothia infections in children with acute myeloid leukemia: A report from the Canadian infections in AML research group.
Wang JY; Brossard J; Cellot S; Dix D; Feusner J; Johnston DL; Lewis V; Mitchell D; Portwine C; Price V; Sung L; Ethier MC; Gillmeister B
Pediatr Hematol Oncol; 2016 Aug; 33(5):277-281. PubMed ID: 27315594
[TBL] [Abstract][Full Text] [Related]
12. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891.
Gamis AS; Howells WB; DeSwarte-Wallace J; Feusner JH; Buckley JD; Woods WG
J Clin Oncol; 2000 May; 18(9):1845-55. PubMed ID: 10784625
[TBL] [Abstract][Full Text] [Related]
13. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
[TBL] [Abstract][Full Text] [Related]
14. Infections in children with down syndrome and acute myeloid leukemia: a report from the Canadian infections in AML research group.
Tran TH; Mitchell D; Dix D; Cellot S; Ethier MC; Gillmeister B; Hitzler J; Lewis V; Yanofsky R; Johnston DL; Portwine C; Price V; Zelcer S; Silva M; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Infect Agent Cancer; 2013 Dec; 8(1):47. PubMed ID: 24289042
[TBL] [Abstract][Full Text] [Related]
15. Enrollment on clinical trials does not improve survival for children with acute myeloid leukemia: A population-based study.
Truong TH; Pole JD; Barber R; Dix D; Kulkarni KP; Martineau E; Randall A; Stammers D; Strahlendorf C; Strother D; Sung L
Cancer; 2018 Oct; 124(20):4098-4106. PubMed ID: 30291800
[TBL] [Abstract][Full Text] [Related]
16. Microbiologically documented fungal infections in pediatric patients with acute myeloid leukemia: 12.5-year experience at a single institution.
Agarwal V; Joyce M
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e528-32. PubMed ID: 24824444
[TBL] [Abstract][Full Text] [Related]
17. The development of a novel protocol for the treatment of de novo childhood acute myeloid leukemia in a single institution in Taiwan.
Yeh TC; Liu HC; Wang LY; Chen SH; Lin WY; Liang DC
J Pediatr Hematol Oncol; 2007 Dec; 29(12):826-31. PubMed ID: 18090930
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus Infection in Children With Acute Myeloid Leukemia: A Report From the Canadian Infection in Acute Myeloid Leukemia Research Group.
Renzi S; Ali S; Portwine C; Mitchell D; Dix D; Lewis V; Price V; Science M; Sung L
Pediatr Infect Dis J; 2018 Feb; 37(2):135-137. PubMed ID: 28806282
[TBL] [Abstract][Full Text] [Related]
19. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Röllig C; Serve H; Hüttmann A; Noppeney R; Müller-Tidow C; Krug U; Baldus CD; Brandts CH; Kunzmann V; Einsele H; Krämer A; Schäfer-Eckart K; Neubauer A; Burchert A; Giagounidis A; Krause SW; Mackensen A; Aulitzky W; Herbst R; Hänel M; Kiani A; Frickhofen N; Kullmer J; Kaiser U; Link H; Geer T; Reichle A; Junghanß C; Repp R; Heits F; Dürk H; Hase J; Klut IM; Illmer T; Bornhäuser M; Schaich M; Parmentier S; Görner M; Thiede C; von Bonin M; Schetelig J; Kramer M; Berdel WE; Ehninger G;
Lancet Oncol; 2015 Dec; 16(16):1691-9. PubMed ID: 26549589
[TBL] [Abstract][Full Text] [Related]
20. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.
Felsenstein S; Orgel E; Rushing T; Fu C; Hoffman JA
Pediatr Infect Dis J; 2015 Apr; 34(4):e78-84. PubMed ID: 25764103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
